Efficacy and Safety With Ziprasidone in First-episode Psychosis
Phase 4
Completed
- Conditions
- First Episode Psychosis
- Registration Number
- NCT01157559
- Lead Sponsor
- Chonbuk National University Hospital
- Brief Summary
The aim of the study is to investigate the efficacy and safety of ziprasidone in patients with first episode psychosis.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 27
Inclusion Criteria
- Patients who meet DSM-IV criteria for first episode schizophrenia, schizophreniform disorder and schizoaffective disorder
Exclusion Criteria
- Patients with previously prescribed antipsychotic medication in 2 weeks or more
- patients with substance-induced psychotic disorder, serious suicide attempt, neurological disorder, etc.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Symptoms assessment by objective rating scales week 8 PANSS total score, SANS, clinical global impression scale, GAF, DAS-S
- Secondary Outcome Measures
Name Time Method Assessment of adverse events by objective rating scales and self report scales two-month. Simpson and Angus rating scale, Barnes Akathisia rating scale and Abnormal Involuntary Movement Scale
Trial Locations
- Locations (3)
Heo psychiatric Hospital
🇰🇷Jeonju, Korea, Republic of
Jeonju Jesus Hospital
🇰🇷Jeonju, Korea, Republic of
Department of Psychiatry, Chonbuk national University Hospital
🇰🇷Jeonju, Korea, Republic of